A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses - American Association for Cancer Research (AACR)
The American Association for Cancer Research reports that a new vaccine designed to prevent pancreatic cancer in high-risk individuals has demonstrated safety and triggered durable immune responses in early testing.
Why it matters
Pancreatic cancer is notoriously difficult to treat, making the development of a preventative vaccine a major potential breakthrough in oncology.
Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. To further refine your search, toggle appropriate sections on or off.
The article is a professional summary of medical research findings from a reputable scientific organization.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in